{"transactions":[{"id":4178921,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":172262,"kind":"person","name":"Gould Kevin S","position":1,"cik":"0001662638","reported_name":"Gould Kevin S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Controls"}}],"security":"Stock Options (Right to buy)","published_at":"2017-10-30T20:56:55.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":14323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests 3,580 shares on 8/9/2018 and 3,581 shares each on 8/9/2019, 8/9/2020, 8/9/2021."}],"balance_after":14323,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":14323},"source":{"system":"sec-edgar","filing":"0001562180-17-003380","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003380/primarydocument.xml","form_type":"4"}},{"id":4178920,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":172262,"kind":"person","name":"Gould Kevin S","position":1,"cik":"0001662638","reported_name":"Gould Kevin S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Controls"}}],"security":"Stock Options (Right to buy)","published_at":"2017-10-30T20:56:55.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":10742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":10742,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":10742},"source":{"system":"sec-edgar","filing":"0001562180-17-003380","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003380/primarydocument.xml","form_type":"4"}},{"id":4178919,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":172262,"kind":"person","name":"Gould Kevin S","position":1,"cik":"0001662638","reported_name":"Gould Kevin S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Controls"}}],"security":"Restricted Stock Units","published_at":"2017-10-30T20:56:55.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":1949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1949,"derivative":{"underlying":"Common Stock","underlying_shares":1949},"source":{"system":"sec-edgar","filing":"0001562180-17-003380","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003380/primarydocument.xml","form_type":"4"}},{"id":4259375,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":172262,"kind":"person","name":"Gould Kevin S","position":1,"cik":"0001662638","reported_name":"Gould Kevin S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Controls"}}],"security":"Common Stock","published_at":"2017-07-11T21:30:09.000Z","date":"2017-07-09","kind":"tax_withholding","acquired":false,"shares":312,"price":117.68,"value":36716.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 834 shares of restricted stock units that vest on 7/9/18."}],"balance_after":1355,"source":{"system":"sec-edgar","filing":"0001562180-17-002466","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002466/primarydocument.xml","form_type":"4"}},{"id":4606102,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":172262,"kind":"person","name":"Gould Kevin S","position":1,"cik":"0001662638","reported_name":"Gould Kevin S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Controls"}}],"security":"Common Stock","published_at":"2016-09-12T21:27:26.000Z","date":"2016-09-08","kind":"sale","acquired":false,"shares":524,"price":110.503,"value":57903.572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.4934 to $110.5402 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18."}],"balance_after":1667,"source":{"system":"sec-edgar","filing":"0000914190-16-000832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000832/edgar.xml","form_type":"4"}}]}